ES415624A3 - Pharmaceutical and diagnostic compositions - Google Patents

Pharmaceutical and diagnostic compositions

Info

Publication number
ES415624A3
ES415624A3 ES415624A ES415624A ES415624A3 ES 415624 A3 ES415624 A3 ES 415624A3 ES 415624 A ES415624 A ES 415624A ES 415624 A ES415624 A ES 415624A ES 415624 A3 ES415624 A3 ES 415624A3
Authority
ES
Spain
Prior art keywords
drug core
prepolymer
carbon atoms
parts
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES415624A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Research Foundation
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Publication of ES415624A3 publication Critical patent/ES415624A3/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Procedure for the preparation of controlled oral gastric residence oral drug formulations, of the type comprising a drug core coated with a pharmaceutically acceptable polymeric film, crosslinked, hydrohydratable, water permeable and adapted to swell in the presence of gastric fluids, characterized in that it comprises the steps of: (a) coating, for example by immersion, a drug core with a solution, for example ethyl acetate, consisting of a prepolymer and a crosslinking agent in a ratio of 8 parts by weight of the prepolymer to 0.15 - 4 parts by weight of crosslinking agent; and (b) crosslinking the resulting coated drug core, under crosslinking conditions, for example by subjecting the coated drug core to a temperature between 10 and 90ºC. at a relative humidity of 30-95%, preferably between and 200 hours; and in that the prepolymer is prepared by copolymerization of (i) 20-90 parts in step of a substituted or unsubstituted dicarboxylic acid or carboxylic acid anhydride, with 1-3 carbon atoms between the 2 carboxylic groups, preferably maleic anhydride; and (ii) 10-80 weight carriers of an alkene of 2 to 6 carbon atoms, styrene or an alkyl vinyl ether in which the alkyl radical contains 1 to 16 carbon atoms, preferably methyl vinyl ether. (Machine-translation by Google Translate, not legally binding)
ES415624A 1972-06-09 1973-06-07 Pharmaceutical and diagnostic compositions Expired ES415624A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26124272A 1972-06-09 1972-06-09

Publications (1)

Publication Number Publication Date
ES415624A3 true ES415624A3 (en) 1976-10-16

Family

ID=22992462

Family Applications (1)

Application Number Title Priority Date Filing Date
ES415624A Expired ES415624A3 (en) 1972-06-09 1973-06-07 Pharmaceutical and diagnostic compositions

Country Status (19)

Country Link
JP (1) JPS4961323A (en)
AU (2) AU5682673A (en)
BE (1) BE800637A (en)
CA (1) CA1040533A (en)
CH (1) CH582002A5 (en)
DD (2) DD112354A5 (en)
DE (1) DE2328580A1 (en)
ES (1) ES415624A3 (en)
FR (1) FR2187290B1 (en)
GB (1) GB1428426A (en)
HU (1) HU167947B (en)
IE (1) IE38151B1 (en)
IL (1) IL42459A (en)
NL (1) NL7307737A (en)
OA (1) OA04931A (en)
PL (1) PL90109B1 (en)
RO (1) RO64146A (en)
SE (1) SE395609B (en)
ZA (1) ZA733897B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207890A (en) 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
JPS5911563B2 (en) * 1980-02-27 1984-03-16 日本原子力研究所 Method for manufacturing multilayer sustained release composites
US4518433A (en) * 1982-11-08 1985-05-21 Fmc Corporation Enteric coating for pharmaceutical dosage forms
DE3314003A1 (en) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim DIVISIBLE TABLET WITH DELAYED ACTIVE SUBSTANCE RELEASE AND METHOD FOR THE PRODUCTION THEREOF
US4657784A (en) * 1986-03-10 1987-04-14 Ecolab Inc. Process for encapsulating particles with at least two coating layers having different melting points
EP0265061B1 (en) * 1986-09-18 1992-01-08 London School of Pharmacy Innovations Ltd Pharmaceutical formulation
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
EP0327295A3 (en) * 1988-02-01 1989-09-06 F.H. FAULDING & CO. LTD. Tetracycline dosage form
AU614328B2 (en) * 1988-02-01 1991-08-29 Mayne Pharma International Pty Ltd Tetracycline dosage form
US5007790A (en) * 1989-04-11 1991-04-16 Depomed Systems, Inc. Sustained-release oral drug dosage form
CA2396782A1 (en) 2000-02-04 2001-08-09 Depomed, Inc. Shell-and-core dosage form approaching zero-order drug release
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
JP2016520653A (en) 2013-06-05 2016-07-14 シンクロニューロン インコーポレイテッド Acamprosate formulation, method of using the same, and combination containing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1050353B (en) * 1966-01-06 1981-03-10 Ceskoslovenska Akademie Ved SUPPORTS FOR BIOLOGICALLY ACTIVE SUBSTANCES
AU454482B2 (en) * 1970-11-05 1974-10-15 Alza Corporation Drug-delivery system

Also Published As

Publication number Publication date
IL42459A0 (en) 1973-08-29
DD112354A5 (en) 1975-04-12
AU5682673A (en) 1974-12-12
CA1040533A (en) 1978-10-17
IE38151L (en) 1973-12-09
DD109309A5 (en) 1974-11-05
GB1428426A (en) 1976-03-17
SE395609B (en) 1977-08-22
JPS4961323A (en) 1974-06-14
ZA733897B (en) 1975-01-29
RO64146A (en) 1978-11-15
BE800637A (en) 1973-12-07
DE2328580A1 (en) 1974-01-10
NL7307737A (en) 1973-12-11
FR2187290A1 (en) 1974-01-18
IL42459A (en) 1976-12-31
AU5935773A (en) 1975-02-20
CH582002A5 (en) 1976-11-30
PL90109B1 (en) 1977-01-31
OA04931A (en) 1980-10-31
FR2187290B1 (en) 1977-04-15
IE38151B1 (en) 1978-01-04
HU167947B (en) 1976-01-28

Similar Documents

Publication Publication Date Title
ES415624A3 (en) Pharmaceutical and diagnostic compositions
JPS5686976A (en) Adhesive composition
JPS56127322A (en) Enteric coating material composition for solid drug
JPS5412372A (en) Thiazolidine derivative and its preparation
JPS5375229A (en) Aqueous coating composition
IE46269L (en) Isoxazole derivatives, process for their manufacture and¹preparations containing these compounds
JPS5622366A (en) Composition for powder coating material
JPS5267318A (en) Increasing of photographic coating fluid viscosity
ES396473A1 (en) Isoindorinjudotaino seiho
JPS5227455A (en) Process for preparing a high polymer material having water absorption properties
JPS5219754A (en) Preparation of crosslinked epihalohydrin polymer composition
GB1422336A (en)
JPS5559149A (en) Aminoacid derivative
ES413876A1 (en) Cycloalkanones containing glycidyl propionate groups
JPS55135834A (en) Photosensitive peeling film
SE7607300L (en) THIAXANTENE ASSOCIATIONS AND PROCEDURES FOR THE PREPARATION OF THEM
JPS5331697A (en) N4,3 , 3 -tri-o-acyl-2 , 2 -cyclocytidines and their preparation
JPS5238561A (en) Molding composition having excellent thickning characteristics
JPS5227715A (en) Process for preparation of gamma-halogeno-delta- unsaturated carboxylic acid ester and/or gamma-lactone derivatives
SE7610968L (en) PROCEDURE FOR THE PREPARATION OF BIOLOGICALLY ACTIVE DI-CARBOXYLIC ACID DERIVATIVES
JPS51115539A (en) Coating composition
JPS527488A (en) Preparation of l-threonine by fermentation
JPS5259183A (en) Preparation of novel cephalosporanic acid derivatives
JPS54135891A (en) Preparation of modified polyvinyl alcohol polymer
NO144667C (en) PROCEDURE FOR THE PREPARATION OF 0- (2,6-DICHLOR-ANILINO) -PHENYLEDIC ACETIC ACID AND ITS SALTS